Strong Bones VI
Natural health product licensed in Canada
- Licence holder
- New Roots Herbal Inc.
- NPN or DIN-HM
- 80115699
- Status
- Active licence
- Licence date
- 20 January 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 16.68 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Mentha x piperita Source : Mentha X piperita - feuille | 7.501 mg | Not calculated |
| Curcuma longa Source : Curcuma longa - Racine Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 2,325 mg Potency : 95 % Curcuminoids | 93 mg | Not calculated |
| Vitamine K2 Source : Ménaquinone 4 | 0.00692 mg | 27.68 µg |
| Vitamine B12 Source : Méthylcobalamine | 0.0125 mg | 50 µg |
| L-Lysine Source : Glycine max - Graine | 25 mg | Not calculated |
| Zinc Source : Monométhionine de Zinc | 0.775 mg | 3,100 µg |
| Cuivre Source : Citrate de cuivre (II) | 0.0775 mg | 310 µg |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 75:1 Dry plant equivalent : 375 mg Potency : 80 % Oligomeric proanthocyanidins | 5 mg | Not calculated |
| Lutéine Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 0.1666 mg | Not calculated |
| L-Proline Source : Glycine max - Graine | 25 mg | Not calculated |
| Phosphate de calcium, hydroxyde Source : Durapatite Potency : 18.5 % Phosphorus | Not specified | Not calculated |
| Phosphate de calcium, hydroxyde Source : Durapatite Potency : 39.9 % Calcium | 300 mg | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Aspergillus niger - En entier | 21 mg | Not calculated |
| Magnésium Source : Bisglycinate de magnésium | 13.01 mg | 52,040 µg |
| Bore Source : Citrate de bore | 0.28 mg | Not calculated |
| Equisetum arvense Source : Equisetum arvense - sommité (herbe) Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 10 mg Potency : 7 % Silicon dioxide | 2.5 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 70 mg Potency : 75 % Epigallocatechin 3-gallate | 3.5 mg | Not calculated |
| Lycopène Source : Solanum lycopersicum - Chair (fruit) | 0.4166 mg | Not calculated |
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 0.0453 mg | Not calculated |
| Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Gallus gallus - Coquille d'oeuf | 125 mg | Not calculated |
| Boswellia serrata Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 150 mg Potency : 35 % Boswellic acids | 25 mg | Not calculated |
| Salix alba | 25 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 15.5 mg | 62,000 µg |
| Manganèse Source : Citrate de manganèse (II) | 0.2325 mg | 930 µg |
| Thiamine Source : Chlorhydrate de thiamine | 0.3875 mg | 1,550 µg |
| Vitamine K2 Source : Ménaquinone 7 | 0.00083 mg | 3.32 µg |
| Vitamine D Source : Cholécalciférol | 4.17 microgram | 16.68 µg |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Eau purifiée, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Calcium intake, when combined with sufficient Vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. For maintaining general health. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones, cartilage, teeth and/or gums and in connective tissue formation. Helps maintain healthy skin and connective tissue formation. Helps normal growth. Helps to build strong bones and teeth. Helps to maintain healthy bones, hair, nail and/or skin. Helps to produce and repair connective tissue. Source of/An antioxidant for the maintenance of good health. Vitamin and mineral supplement. Helps in the development and maintenance of bones and teeth (especially in children and young adults).Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life).Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life).As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis.Helps support bone health.Helps in energy metabolism, tissue formation and bone development.Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women. Helps to minimize discomfort due to moderate intensity aerobic exercise in postmenopausal women. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise.Helps to minimize discomfort due to moderate intensity aerobic exercise.Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise. (NEM) Starts to reduce joint pain due to moderate intensity aerobic exercise in as little/as quickly as 1 day and joint stiffness in as little/as quickly as 5 days. (NEM is) Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5-7 days).(NEM) Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as the first day). Helps maintain healthy calcium metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80115699
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.